Differences in biofilm formation and aggregative adherence between β-lactam susceptible and β-lactamases producing P. mirabilis clinical isolates

New Microbiologica

Volumn 33, Issue 1, 2010, Pages 37-45

  Nucleo, Elisabetta ^a   Fugazza, Giulia ^a   Migliavacca, Roberta ^a   Spalla, Melissa ^a   Comelli, Mario ^a   Pagani, Laura ^a   Debiaggi, Maurizia ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

lactamases; Biofilm; Proteus mirabilis

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE;

ANIMAL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ADHERENCE; BIOFILM; CELL LINE; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; GENETICS; HAPLORHINI; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHYSIOLOGY; PROTEUS INFECTION; PROTEUS MIRABILIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BETA-LACTAMASES; BETA-LACTAMS; BIOFILMS; CELL LINE; DRUG RESISTANCE, BACTERIAL; HAPLORHINI; HUMANS; MICROBIAL SENSITIVITY TESTS; PROTEUS INFECTIONS; PROTEUS MIRABILIS;

BACTERIA (MICROORGANISMS); LURIA; PROTEUS MIRABILIS;

EID: 77950271036     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. BAGGE N., SCHUSTER M., HENTZER M., CIOFU O., GIVSKOV M., GREENBERG E.P., HØIBY N. (2004). Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrobial Agents and Chemotherapy. 48, 1175-1187.
2. BAHRANI F.K., JOHNSON D.E., ROBBINS D., MOBLEY H.L. (1991). Proteus, mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infection and Immunity. 59, 3574-3580.
3. BROMBACHER E., BARATTO A., DOREL C., LANDINI P. (2006). Gene expression regulation by the Curli activator CsgD protein: modulation of cellulose biosynthesis and control of negative determinants for microbial adhesion. Journal of Bacteriology. 188, 2027-2037.
4. CASTONGUAY M.H., VAN DER SCHAAF S., KOESTER W., KROONEMAN J., VAN DER MEER W., HARMSEN H., LANDINI P. (2006). Biofilm formation by Escherichia coli is stimulated by synergistic interactions and co-adhesion mechanisms with adherence-proficient bacteria. Research in Microbiology. 157, 471-478.
5. COKER C., POORE C.A., Li X., MOBLEY H.L. (2000). Pathogenesis of Proteus mirabilis urinary tract infection. Microbes and Infection. 12, 1497-1505.
6. COOK S.W., MODY N., VALLE J., HULL R. (1995). Molecular cloning of Proteus mirabilis uroepithelial cell adherence (uca) genes. Infection and Immunity. 63, 2082-2086.
7. CRAVIOTO A., GROSS R.J., SCOTLAND S.M., ROWE B. (1979). An adhesive factor found in strains of Escherichia coli belonging to the traditional infantile enteropathogenic serotypes. Current Microbiology. 3, 95-99.
8. DE CHAMPS C., POIREL L., BONNET R., SIROT D., CHANAL C., SIROT J., NORDMANN P. (2002). Prospective survey of beta-lactamases produced by ceftazidime resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrobial Agents and Chemotheretapy. 46, 3031-3034.
9. DEVELOPMENT CORE TEAM (2008). R: A language and environment for statistical computing. R Foundation for Statistical Computing,Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org
10. GALLANT C., DANIELS C., LEUNG J. M., GHOSH A. S., YOUNG K. D., LAKSHMI P. K., BURROWS L.L. (2005). Common-lactamases inhibit bacterial biofilm formation. Molecular Microbiology. 58, 1012-1024.
11. GANDERTON L., CHAWLA J., WINTERS C., WIMPENNY J., STICKLER D. (1992). Scanning electron microscopy of bacterial biofilms on indwelling bladder catheters. European Journal of Clinical Microbiology and Infectious Diseases. 11, 789-797.
12. GRIFFITH D.P., MUSHER D.M., ITIN C (1976). Urease. The primary cause of infection-induced urinary stones. Investigative Urolology. 13, 346-350.
13. HOFFMAN L.R., D'ARGENIO D.A., MACCOSS MJ., ZHANG Z., JONES R.A., MILLER S.I. (2005). Aminoglycoside antibiotics induce bacterial biofilm formation. Nature. 436, 1171-1175
14. HOYLE, B.D., ALCANTARA J., COSTERTON J.W. (1992). Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrobial Agents and Chemotherapy. 36, 2054-2056.
15. JANSEN A.M., LOCKATELL C.V., JOHNSON D.E., MOBLEY H.L. (2003). Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection. Infection and Immunity. 71, 3607-3613.
16. KUNIN C.M. (1989). Blockage of urinary catheters: role of microorganisms and constituents of the urine on formation of encrustations. Journal of Clinical Epidemiology. 42, 835-842.
17. LUZZARO F., BRIGANTE G., D'ANDREA M.M., PINI B., GIANI T., MANTENGOLI E., ROSSOLINI G.M., TONIOLO A. (2009). Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type betalactamase: epidemiology and clinical management. International Journal of Antimicrobial Agents. 33, 328-333.
18. LUZZARO F., VIGANÒ E.F., FOSSATI D., GROSSI A., SALA A., STURLA C., SAUDELLI M., TONIOLO A. (2002). Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals. European Journal of Clinical Microbiology and Infectious Diseases. 21, 849-855.
19. MAH T.F.C., O'TOOLE G.A. (2001) Mechanisms of biofilm resistance to antimicrobial agents. TRENDS in Microbiology. 9, 34-39.
20. MIGLIAVACCA R., MIGLIAVACCA A., NUCLEO E., CIAPONI A., SPALLA M., DE LUCA C., PAGANI L. (2007a). Molecular epidemiology of ES L producing P. mirabilis strains from a long-term care and rehabilitation facility in Italy. New Microbiologica. 30, 362-366.
21. MIGLIAVACCA R., NUCLEO E. D'ANDREA M.M., SPALLA M., GIANI T., PAGANI L. (2007b). Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation faculties. New Microbiologica. 30, 295-298.
22. MOBLEY H.L., BELAS R. (1995). Swarming and pathogenicity of Proteus mirabilis in the urinary tract. TRENDS in microbiology. 3, 280-284.
23. MOBLEY H.L., WARREN J.W. (1987). Urease-positive bacteriuria and obstruction of long-term urinary catheters. Journal of Clinical Microbiology. 25, 2216-2217.
24. MORRIS N.S., STICKLER D.J., MCLEAN R.J.C. (1999). The development of bacterial biofilms on indwelling catheters. World Journal of Urology 17, 345-350.
25. MORRIS N.S., STICKLER D.J., WINTERS C. (1997). Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? British Journal of Urology. 80, 58-63.
26. O'HARA C.M., BRENNER F.W., MILLER J.M. (2000). Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clinical Microbiology Reviews. 13, 534-546.
27. O' TOOLE G.A., KOLTER R. (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Molecular Microbiology 30, 295-304.
28. ROCHA S.P.D., ELIAS W.P., CIANCIARULLO A.M., MENEZES M.A., NARA J.M., PIAZZA R.M.F., SILVA M.R.L., MOREIRA C.G., PELAYO J.S. (2007). Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells. FEMS Immunology & Medical Microbiology. 51, 319-326.
29. RÖMLING U., ROHDE M., OLSEÅN A., NORMARK S., REINKOÈSTER J. (2000). AgfD, the checkpoint of multicellular and aggregative behaviour in Salmonella typhimurium regulates at least two independent pathways. Molecular Microbiology. 36, 10-23.
30. SARENEVA T., HOLTHOFER H., KORHONEN T.K. (1990). Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Infection and Immunity. 58, 3330-3336.
31. STEWART P.S., COSTERTON J.W. (2001). Antibiotic resistance of bacteria in biofilms. Lancet Review. 358, 135-138.
32. STICKLER D.J., MORGAN S.D. (2006). Modulation of crystalline Proteus mirabilis biofilm development on urinary catheters. Journal of Medical Microbiology. 55, 489-494.
33. STICKLER DJ., MORRIS N., MORENO M-C., SABBUBA N. (1998) Studies on the formation of crystalline bac- terial biofilms on urethral catheters. Eur J Clin Microbiology and Infectious Disease. 17, 649-652.
34. STÜRENBURG E., MACK D. (2003). Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. Journal of Infect. 47, 273-295.
35. TOLKOFF-RUBIN N.E., RUBIN R.H.U. (1986). Urinary tract infection: significance and management. Bull NY Acad Med. 62, 131-148.
36. TENKE P., KOVACS B., JÄCKEL M., NAGY E. (2006). The role of biofilm infection in urology. World Journal of Urology. 24, 13-20.
37. WINOKUR P.L., CANTON R., CASELLAS J.M., LEGAKIS N. (2001). Variations in the prevalence ofstrains expressing an extend-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region. Clinical Infectious Diseases. 32, 94-103.